id,analyte_A260A280Ratio,vital_status,gender,race,ethnicity,disease_type,primary_site,investigation,days_to_death,tissue_source_site_label,country_of_sample_procurement,portion_is_ffpe,pathologic_t_label,pathologic_n_label,histological_diagnosis_label,pathologic_stage_label,PlateCenter,PlateCenterFlag,shannon
13722.58cfa830e4b0c9d6adf6be66,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,University of Pittsburgh,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A221-26,TRUE,0.307633571
13722.58cfa831e4b0c9d6adf6c7cb,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,NA,Medical College of Georgia,United States,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I,2317-26,TRUE,0.699106259
13722.58cfa831e4b0c9d6adf6c8ea,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,2717,MD Anderson Cancer Center,United States,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA,2317-26,TRUE,0.057167381
13722.58cfa831e4b0c9d6adf6cb00,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Asterand,Russia,NO,T1b,N0,Cervical Squamous Cell Carcinoma,Not available,A245-26,TRUE,0.008237985
13722.58cfa831e4b0c9d6adf6ccdf,NA,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,University Health Network,Canada,NO,T3,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A221-26,TRUE,0.034094179
13722.58cfa831e4b0c9d6adf6cd9c,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,602,BLN - University Of Chicago,United States,NO,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A233-26,TRUE,0.08625354
13722.58cfa832e4b0c9d6adf6ce58,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,International Genomics Consortium,United States,NO,T1b2,N1,Cervical Squamous Cell Carcinoma,Not available,A245-26,TRUE,0.005092048
13722.58cfa832e4b0c9d6adf6ceac,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A21C-26,TRUE,0.082616578
13722.58cfa832e4b0c9d6adf6cf7f,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,ABS - IUPUI,United States,NO,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A221-26,TRUE,0.089539973
13722.58cfa832e4b0c9d6adf6cfb8,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,International Genomics Consortium,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A210-26,TRUE,0.067380068
13722.58cfa832e4b0c9d6adf6d0d4,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,International Genomics Consortium,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III,A221-26,TRUE,0.045518152
13722.58cfa832e4b0c9d6adf6d128,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,612,MD Anderson,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A210-26,TRUE,0.168703143
13722.58cfa832e4b0c9d6adf6d1a4,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,Asterand,Vietnam,NO,T3,N1,Not available,Stage IIIA,A267-26,TRUE,0.018270178
13722.58cfa832e4b0c9d6adf6d3d0,NA,Dead,MALE,WHITE,Not available,Esophageal Carcinoma,Esophagus,TCGA-ESCA,131,University of Michigan,United States,NO,T3,N0,Not available,Stage IIB,A248-26,TRUE,0.071255924
13722.58cfa832e4b0c9d6adf6d578,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA,A40D-26,TRUE,0.02610695
13722.58cfa832e4b0c9d6adf6d57a,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,ILSbio,Vietnam,NO,T3,N1,Not available,Stage III,A28P-26,TRUE,0.01647545
13722.58cfa832e4b0c9d6adf6d5b4,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA,A248-26,TRUE,1.439790492
13722.58cfa832e4b0c9d6adf6d618,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,ILSbio,Vietnam,NO,T2,N0,Not available,Stage IIA,A28P-26,TRUE,0.029003402
13722.58cfa831e4b0c9d6adf6c710,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,1671,MD Anderson Cancer Center,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,2317-26,TRUE,0.03174882
13722.58cfa831e4b0c9d6adf6c737,NA,Dead,MALE,BLACK OR AFRICAN AMERICAN,Not available,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,560,MD Anderson Cancer Center,United States,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Stage II,2317-26,TRUE,0.034743201
13722.58cfa831e4b0c9d6adf6c76c,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,2166,MD Anderson Cancer Center,United States,NO,T4a,N2,Head and Neck Squamous Cell Carcinoma,Stage IVA,2317-26,TRUE,0.061416404
13722.58cfa831e4b0c9d6adf6c757,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,NA,MD Anderson Cancer Center,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II,2317-26,TRUE,0.058334422
13722.58cfa831e4b0c9d6adf6cb0e,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Asterand,Ukraine,NO,T1b,N0,Cervical Squamous Cell Carcinoma,Not available,A245-26,TRUE,0.013729686
13722.58cfa831e4b0c9d6adf6ccf8,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,BLN - University Of Chicago,United States,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A233-26,TRUE,0.056497852
13722.58cfa832e4b0c9d6adf6ce60,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,BLN - Cleveland Clinic,United States,NO,T3b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A233-26,TRUE,0.105807565
13722.58cfa832e4b0c9d6adf6ceed,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,International Genomics Consortium,United States,NO,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A221-26,TRUE,0.048892213
13722.58cfa832e4b0c9d6adf6cfd8,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,International Genomics Consortium,United States,NO,T2b,N1,Cervical Squamous Cell Carcinoma,Not available,A232-26,TRUE,0.002746053
13722.58cfa832e4b0c9d6adf6cff0,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,ABS - IUPUI,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A221-26,TRUE,0.074233427
13722.58cfa832e4b0c9d6adf6d058,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,Asterand,Ukraine,NO,T3,N0,Not available,Stage IIA,A267-26,TRUE,0.008237985
13722.58cfa832e4b0c9d6adf6d116,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Washington University,United States,NO,T3,N0,Cervical Squamous Cell Carcinoma,Not available,A245-26,TRUE,0
13722.58cfa832e4b0c9d6adf6d16e,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,Asterand,Russia,NO,T3,N0,Not available,Stage IIB,A28P-26,TRUE,0.021566804
13722.58cfa832e4b0c9d6adf6d3cd,NA,Dead,MALE,WHITE,Not available,Esophageal Carcinoma,Esophagus,TCGA-ESCA,9,University of Michigan,United States,NO,T3,N1,Not available,Stage III,A248-26,TRUE,1.44871388
13722.58cfa832e4b0c9d6adf6d35e,NA,Dead,MALE,WHITE,Not available,Esophageal Carcinoma,Esophagus,TCGA-ESCA,556,University of Michigan,United States,NO,T3,N1,Not available,Stage IIIA,A248-26,TRUE,1.265234219
13722.58cfa832e4b0c9d6adf6d407,NA,Alive,MALE,Not available,Not available,Uveal Melanoma,Eye,TCGA-UVM,NA,University of Liverpool,United Kingdom,NO,T3a,NX,Not available,Stage IIB,A40D-26,TRUE,0.008237985
13722.58cfa832e4b0c9d6adf6d630,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA,A267-26,TRUE,0.020615827
13722.58cfa832e4b0c9d6adf6d545,NA,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,University of Michigan,United States,NO,T1,N0,Not available,Stage I,A248-26,TRUE,0.508911668
13722.58cfa832e4b0c9d6adf6d602,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,ILSbio,Vietnam,NO,T2,N1,Not available,Stage IIB,A248-26,TRUE,1.475553842
13722.58cfa830e4b0c9d6adf6c2d8,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,142,University of Pittsburgh,United States,NO,T3b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A221-26,TRUE,0.152659425
13722.58cfa831e4b0c9d6adf6c50c,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,ILSbio,Vietnam,NO,T2,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A210-26,TRUE,0.113258518
13722.58cfa831e4b0c9d6adf6c610,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,NA,"University Health Network, Toronto",Canada,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Not available,2317-26,TRUE,0.010583864
13722.58cfa831e4b0c9d6adf6c819,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,NA,University of Pittsburgh,United States,NO,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,2317-26,TRUE,0.05446951
13722.58cfa831e4b0c9d6adf6c8bc,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A210-26,TRUE,0.085744633
13722.58cfa831e4b0c9d6adf6c8c2,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A210-26,TRUE,0.066873069
13722.58cfa831e4b0c9d6adf6c9b5,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A210-26,TRUE,0.075805446
13722.58cfa831e4b0c9d6adf6c9d5,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A210-26,TRUE,0.060593609
13722.58cfa831e4b0c9d6adf6cb17,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Asterand,United States,NO,T1b1,N1,Cervical Squamous Cell Carcinoma,Not available,A232-26,TRUE,0.008237985
13722.58cfa831e4b0c9d6adf6cd50,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,1423,BLN - University Of Chicago,United States,NO,T3a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A233-26,TRUE,0.060465426
13722.58cfa831e4b0c9d6adf6cdc5,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,168,BLN - University Of Chicago,United States,NO,T3a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A233-26,TRUE,0.116946619
13722.58cfa832e4b0c9d6adf6ce0f,NA,Alive,MALE,WHITE,HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A210-26,TRUE,0.044275037
13722.58cfa832e4b0c9d6adf6ce18,NA,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,272,BLN - University Of Chicago,United States,NO,T2b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A210-26,TRUE,0.07316159
13722.58cfa832e4b0c9d6adf6cf1a,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,NA,ABS - IUPUI,United States,NO,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA,2317-26,TRUE,0.008237985
13722.58cfa832e4b0c9d6adf6d0ac,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,Asterand,Russia,NO,T3,N0,Not available,Stage IIA,A248-26,TRUE,1.479606701
13722.58cfa832e4b0c9d6adf6d12e,NA,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,MD Anderson,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A210-26,TRUE,0.070790965
13722.58cfa832e4b0c9d6adf6d158,NA,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Memorial Sloan Kettering,United States,NO,T1b1,N0,Endocervical Adenocarcinoma of the Usual Type,Not available,A232-26,TRUE,0.029403402
13722.58cfa832e4b0c9d6adf6d034,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,International Genomics Consortium,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A233-26,TRUE,0.108058855
13722.58cfa832e4b0c9d6adf6d170,NA,Alive,MALE,WHITE,Not available,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,Mayo Clinic,United States,NO,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A23Q-26,TRUE,0.071461072
13722.58cfa832e4b0c9d6adf6d655,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA,A248-26,TRUE,0.868723857
13722.58cfa82fe4b0c9d6adf6b8e2,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,Breast,TCGA-BRCA,NA,Christiana Healthcare,United States,YES,T1,N0,Other  specify,Stage IA,A22S-26,FALSE,1.329088597
13722.58cfa830e4b0c9d6adf6be78,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,205,Christiana Healthcare,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A21C-26,TRUE,0.0694012
13722.58cfa831e4b0c9d6adf6c3cb,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Medical College of Wisconsin,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available,A20X-26,TRUE,0.010983864
13722.58cfa831e4b0c9d6adf6c4d0,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,University of Pittsburgh,United States,NO,T3a,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A221-26,TRUE,0.057661853
13722.58cfa831e4b0c9d6adf6c87c,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,14,MD Anderson Cancer Center,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,2317-26,TRUE,0.061436377
13722.58cfa831e4b0c9d6adf6c8b0,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,2570,MD Anderson Cancer Center,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II,2317-26,TRUE,0.30473446
13722.58cfa831e4b0c9d6adf6cb1a,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,Asterand,Ukraine,NO,T2,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A233-26,TRUE,0.047420107
13722.58cfa831e4b0c9d6adf6cc87,NA,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,University Health Network,Canada,NO,T2,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II,A221-26,TRUE,0.055254969
13722.58cfa831e4b0c9d6adf6cd12,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,739,BLN - University Of Chicago,United States,NO,T2b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A233-26,TRUE,0.024312395
13722.58cfa831e4b0c9d6adf6cd1e,NA,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,University of North Carolina,United States,NO,T1b1,N0,Endocervical Type of Adenocarcinoma,Not available,A232-26,TRUE,0.008237985
13722.58cfa831e4b0c9d6adf6cd64,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,BLN - University Of Chicago,United States,NO,T4,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A233-26,TRUE,0.051724672
13722.58cfa831e4b0c9d6adf6cd7e,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,Ohio State University,United States,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A221-26,TRUE,0.044675037
13722.58cfa831e4b0c9d6adf6cd90,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,Ohio State University,United States,NO,T4,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II,A221-26,TRUE,0.04274474
13722.58cfa832e4b0c9d6adf6cef7,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,24,Asterand,Ukraine,NO,T3,N0,Not available,Stage IB,A28P-26,TRUE,0.030246865
13722.58cfa832e4b0c9d6adf6ce5a,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,BLN - Cleveland Clinic,United States,NO,T3a,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A221-26,TRUE,0.08842664
13722.58cfa832e4b0c9d6adf6cefe,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,Christiana Healthcare,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A221-26,TRUE,0.058822659
13722.58cfa832e4b0c9d6adf6cfa8,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,BLN - Cleveland Clinic,United States,NO,T3b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A221-26,TRUE,0.106237353
13722.58cfa832e4b0c9d6adf6d020,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,BLN - Cleveland Clinic,United States,NO,T4a,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A21C-26,TRUE,0.045548346
13722.58cfa832e4b0c9d6adf6d40e,NA,Dead,MALE,Not available,Not available,Uveal Melanoma,Eye,TCGA-UVM,40,University of Liverpool,United Kingdom,NO,T4b,NX,Not available,Stage IIIB,A40D-26,TRUE,0.005492048
13722.58cfa832e4b0c9d6adf6d478,NA,Dead,MALE,Not available,Not available,Uveal Melanoma,Eye,TCGA-UVM,114,University of Liverpool,United Kingdom,NO,T4a,NX,Not available,Stage IV,A40D-26,TRUE,0.010983864
13722.58cfa832e4b0c9d6adf6d40a,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA,A40D-26,TRUE,0.002746053
13722.58cfa832e4b0c9d6adf6d4da,NA,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Eye,TCGA-UVM,NA,University of Liverpool,United Kingdom,NO,T2a,NX,Not available,Stage IIA,A40D-26,TRUE,0.013729686
13722.58cfa831e4b0c9d6adf6cd16,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,BLN - University Of Chicago,United States,NO,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A233-26,TRUE,0.064924546
13722.58cfa831e4b0c9d6adf6c4d6,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,ILSbio,Vietnam,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A21C-26,TRUE,0.202751171
13722.58cfa831e4b0c9d6adf6c5f0,1.9,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Stomach,TCGA-STAD,122,Indivumed,Germany,NO,T3,N3,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV,A326-26,TRUE,0.035488503
13722.58cfa831e4b0c9d6adf6c655,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Stomach,TCGA-STAD,NA,Indivumed,Germany,NO,T2b,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA,A326-26,TRUE,0.028452425
13722.58cfa832e4b0c9d6adf6cf6a,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,International Genomics Consortium,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A233-26,TRUE,0.33011817
13722.58cfa832e4b0c9d6adf6d160,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,Asterand,Ukraine,NO,T2,N1,Not available,Stage IIB,A267-26,TRUE,0.013329686
13722.58cfa832e4b0c9d6adf6d3ee,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T3b,N0,Not available,Stage IIIA,A40D-26,TRUE,0.005492048
13722.58cfa832e4b0c9d6adf6d3bc,NA,Alive,FEMALE,Not available,Not available,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,University of Michigan,United States,NO,T3,N2,Not available,Not available,A248-26,TRUE,0.167167215
13722.58cfa832e4b0c9d6adf6d42e,NA,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Eye,TCGA-UVM,NA,University of Liverpool,United Kingdom,NO,T3a,NX,Not available,Stage IIB,A40D-26,TRUE,0.008237985
13722.58cfa832e4b0c9d6adf6d4b4,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA,A40D-26,TRUE,0.005492048
13722.58cfa832e4b0c9d6adf6d514,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T4d,N0,Not available,Stage IIIC,A40D-26,TRUE,0.008237985
13722.58cfa832e4b0c9d6adf6d4fe,NA,Alive,FEMALE,WHITE,Not available,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,University of Michigan,United States,NO,T1,N0,Not available,Stage I,A267-26,TRUE,0.005492048
13722.58cfa832e4b0c9d6adf6d5d7,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,ILSbio,Vietnam,NO,T2,N0,Not available,Stage IIA,A248-26,TRUE,0.226185051
13722.58cfa832e4b0c9d6adf6d5cc,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA,A248-26,TRUE,0.31619074
13722.58cfa832e4b0c9d6adf6d5d0,NA,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,Christiana Care,United States,NO,Not available,Not available,Not available,Not available,A267-26,TRUE,0.03054882
13722.58cfa832e4b0c9d6adf6d608,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,ILSbio,Vietnam,NO,T3,N1,Not available,Stage IV,A28P-26,TRUE,0.035737525
13722.58cfa832e4b0c9d6adf6d84d,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,ILSbio,Vietnam,NO,T2,N0,Not available,Stage II,A267-26,TRUE,0.034494179
13722.58cfa832e4b0c9d6adf6d5e3,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA,A267-26,TRUE,0.069629091
13722.58cfa831e4b0c9d6adf6c3d4,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,543,Medical College of Wisconsin,United States,NO,Not available,Not available,Mucinous Adenocarcinoma of Endocervical Type,Not available,A20X-26,TRUE,0.013329686
13722.58cfa831e4b0c9d6adf6c4d2,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,ILSbio,Vietnam,NO,T2,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A210-26,TRUE,0.065937974
13722.58cfa831e4b0c9d6adf6c62c,1.9,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,Stomach,TCGA-STAD,NA,Indivumed,Germany,NO,T4,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV,A326-26,TRUE,0.022712395
13722.58cfa831e4b0c9d6adf6c6c3,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,UNC,United States,NO,T2b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A233-26,TRUE,0.346357581
13722.58cfa831e4b0c9d6adf6c7ce,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,218,MD Anderson Cancer Center,United States,NO,T4a,N1,Head and Neck Squamous Cell Carcinoma,Stage IVA,2317-26,TRUE,0.555063409
13722.58cfa831e4b0c9d6adf6c8e0,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,294,Memorial Sloan Kettering,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A21C-26,TRUE,0.106699085
13722.58cfa831e4b0c9d6adf6c958,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A21C-26,TRUE,0.166405225
13722.58cfa831e4b0c9d6adf6c99c,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,321,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A233-26,TRUE,0.163758905
13722.58cfa831e4b0c9d6adf6c9ce,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A233-26,TRUE,0.074339144
13722.58cfa831e4b0c9d6adf6cb30,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Asterand,Russia,NO,T2a,N0,Cervical Squamous Cell Carcinoma,Not available,A20X-26,TRUE,0.010583864
13722.58cfa832e4b0c9d6adf6ce0e,NA,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A21C-26,TRUE,0.062552699
13722.58cfa832e4b0c9d6adf6cfc9,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,International Genomics Consortium,United States,NO,T2a2,N0,Cervical Squamous Cell Carcinoma,Not available,A20X-26,TRUE,0.026257928
13722.58cfa832e4b0c9d6adf6cfe8,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,BLN - Cleveland Clinic,United States,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A210-26,TRUE,1.472107167
13722.58cfa832e4b0c9d6adf6d0e2,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,Asterand,Russia,NO,T3,N1,Not available,Stage IIIA,A248-26,TRUE,0.295564463
13722.58cfa832e4b0c9d6adf6d126,NA,Alive,MALE,WHITE,HISPANIC OR LATINO,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,International Genomics Consortium,United States,NO,T2,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A221-26,TRUE,0.054399807
13722.58cfa832e4b0c9d6adf6d196,NA,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,ABS - Lahey Clinic,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A23Q-26,TRUE,0.111455303
13722.58cfa832e4b0c9d6adf6d2a6,NA,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Memorial Sloan Kettering,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available,A20X-26,TRUE,0.010983864
13722.58cfa832e4b0c9d6adf6d362,NA,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,University of Michigan,United States,NO,T1,N0,Not available,Stage I,A267-26,TRUE,0.013729686
13722.58cfa832e4b0c9d6adf6d388,NA,Alive,FEMALE,WHITE,Not available,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,University of Michigan,United States,NO,T1,N0,Not available,Stage IA,A267-26,TRUE,0.013729686
13722.58cfa832e4b0c9d6adf6d386,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,ILSbio,Vietnam,NO,T3,N1,Not available,Stage III,A267-26,TRUE,0.91973335
13722.58cfa832e4b0c9d6adf6d418,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T3b,N0,Not available,Stage IIIA,A40D-26,TRUE,0.010983864
13722.58cfa832e4b0c9d6adf6d474,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,389,Institut Curie,France,NO,T4c,N0,Not available,Stage IIIB,A40D-26,TRUE,0.025057928
13722.58cfa832e4b0c9d6adf6d416,NA,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Eye,TCGA-UVM,NA,University of Liverpool,United Kingdom,NO,T2a,NX,Not available,Stage IIA,A40D-26,TRUE,0.010983864
13722.58cfa832e4b0c9d6adf6d4aa,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T4b,N0,Not available,Stage IIIB,A40D-26,TRUE,0.012778708
13722.58cfa832e4b0c9d6adf6d426,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T4b,N0,Not available,Stage IIIB,A40D-26,TRUE,0.018421156
13722.58cfa832e4b0c9d6adf6d4a6,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA,A40D-26,TRUE,0.026657928
13722.58cfa832e4b0c9d6adf6d4c6,NA,Alive,MALE,Not available,Not available,Uveal Melanoma,Eye,TCGA-UVM,NA,University of Liverpool,United Kingdom,NO,T3a,NX,Not available,Stage IIB,A40D-26,TRUE,0.010583864
13722.58cfa832e4b0c9d6adf6d4ca,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T4e,N0,Not available,Stage IV,A40D-26,TRUE,0.018270178
13722.58cfa832e4b0c9d6adf6d54e,NA,Alive,FEMALE,WHITE,Not available,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,University of Michigan,United States,NO,T2,N1,Not available,Stage IIB,A28P-26,TRUE,0.034917552
13722.58cfa832e4b0c9d6adf6d528,NA,Alive,FEMALE,WHITE,Not available,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,University of Michigan,United States,NO,T1,N0,Not available,Stage I,A267-26,TRUE,0.025135999
13722.58cfa832e4b0c9d6adf6d4f8,NA,Dead,MALE,WHITE,Not available,Esophageal Carcinoma,Esophagus,TCGA-ESCA,149,University of Michigan,United States,NO,T3,N1,Not available,Stage IV,A28P-26,TRUE,0.01607545
13722.58cfa832e4b0c9d6adf6d5a8,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA,A248-26,TRUE,0.290092648
13722.58cfa832e4b0c9d6adf6d4fa,NA,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,University of Michigan,United States,NO,T3,N2,Not available,Stage IIIB,A267-26,TRUE,0.013329686
13722.58cfa832e4b0c9d6adf6d5f8,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA,A248-26,TRUE,0.209247147
13722.58cfa831e4b0c9d6adf6c4e4,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,3046,Medical College of Wisconsin,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available,A20X-26,TRUE,0.025873106
13722.58cfa831e4b0c9d6adf6c63a,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,Stomach,TCGA-STAD,NA,Indivumed,Germany,NO,T2a,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB,A326-26,TRUE,0.016499228
13722.58cfa831e4b0c9d6adf6c68f,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,UNC,United States,NO,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A233-26,TRUE,0.144794344
13722.58cfa831e4b0c9d6adf6c741,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,577,MD Anderson Cancer Center,United States,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III,2317-26,TRUE,0.113757954
13722.58cfa831e4b0c9d6adf6c830,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,1081,MD Anderson Cancer Center,United States,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Stage II,2317-26,TRUE,0.090645643
13722.58cfa831e4b0c9d6adf6c8ba,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A210-26,TRUE,0.212181855
13722.58cfa831e4b0c9d6adf6c9e6,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A233-26,TRUE,0.069672784
13722.58cfa831e4b0c9d6adf6ca0f,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,547,Memorial Sloan Kettering,United States,NO,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A233-26,TRUE,0.087677423
13722.58cfa831e4b0c9d6adf6caf8,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Asterand,Russia,NO,T2a,N0,Cervical Squamous Cell Carcinoma,Not available,A20X-26,TRUE,0.049710073
13722.58cfa831e4b0c9d6adf6cb28,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,Asterand,Ukraine,NO,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A233-26,TRUE,0.052359095
13722.58cfa831e4b0c9d6adf6cc1e,NA,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,University Health Network,Canada,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A221-26,TRUE,0.104869605
13722.58cfa831e4b0c9d6adf6cc63,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Asterand,Russia,NO,T2a2,N0,Cervical Squamous Cell Carcinoma,Not available,A20X-26,TRUE,0.022312395
13722.58cfa831e4b0c9d6adf6cc3e,NA,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,University Health Network,Canada,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A221-26,TRUE,0.087803043
13722.58cfa831e4b0c9d6adf6cc9c,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,BLN - University Of Chicago,United States,NO,T3a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A233-26,TRUE,0.067066285
13722.58cfa831e4b0c9d6adf6ccd2,NA,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,University Health Network,Canada,NO,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II,A221-26,TRUE,0.061008035
13722.58cfa832e4b0c9d6adf6d11f,NA,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Memorial Sloan Kettering,United States,NO,T1b2,N0,Cervical Squamous Cell Carcinoma,Not available,A20X-26,TRUE,0.008237985
13722.58cfa832e4b0c9d6adf6d190,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Memorial Sloan Kettering,United States,NO,T2a1,N0,Cervical Squamous Cell Carcinoma,Not available,A20X-26,TRUE,0.030797842
13722.58cfa832e4b0c9d6adf6d19c,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Roswell Park,United States,NO,T1b2,N0,Cervical Squamous Cell Carcinoma,Not available,A20X-26,TRUE,0.018821156
13722.58cfa832e4b0c9d6adf6d19a,NA,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Memorial Sloan Kettering,United States,NO,T1b1,N0,Cervical Squamous Cell Carcinoma,Not available,A20X-26,TRUE,0.026257928
13722.58cfa832e4b0c9d6adf6d1f4,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,Asterand,Russia,NO,T1,N1,Not available,Stage IIB,A267-26,TRUE,0.021166804
13722.58cfa832e4b0c9d6adf6d222,NA,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Memorial Sloan Kettering,United States,NO,T2b,N1,Endocervical Type of Adenocarcinoma,Not available,A20X-26,TRUE,0.005492048
13722.58cfa832e4b0c9d6adf6d322,NA,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,University of Michigan,United States,NO,Not available,Not available,Not available,Not available,A248-26,TRUE,0.191174632
13722.58cfa832e4b0c9d6adf6d37a,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA,A267-26,TRUE,0.070941465
13722.58cfa832e4b0c9d6adf6d3ea,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA,A40D-26,TRUE,0.020766804
13722.58cfa832e4b0c9d6adf6d1fa,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,BLN - Cleveland Clinic,United States,NO,T2,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A210-26,TRUE,1.071719348
13722.58cfa832e4b0c9d6adf6d414,NA,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Eye,TCGA-UVM,NA,University of Liverpool,United Kingdom,NO,T3a,NX,Not available,Stage IIB,A40D-26,TRUE,0.01607545
13722.58cfa832e4b0c9d6adf6d4be,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB,A40D-26,TRUE,0.010983864
13722.58cfa832e4b0c9d6adf6d498,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T4b,N0,Not available,Stage IIIB,A40D-26,TRUE,0.014153522
13722.58cfa832e4b0c9d6adf6d4a7,NA,Alive,MALE,Not available,Not available,Uveal Melanoma,Eye,TCGA-UVM,NA,University of Liverpool,United Kingdom,NO,T4b,NX,Not available,Stage IIIB,A40D-26,TRUE,0.01567545
13722.58cfa832e4b0c9d6adf6d55a,NA,Alive,MALE,WHITE,Not available,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,University of Michigan,United States,NO,T1,N1,Not available,Stage IIB,A267-26,TRUE,0.026257928
13722.58cfa832e4b0c9d6adf6d4a2,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA,A40D-26,TRUE,0.008237985
13722.58cfa832e4b0c9d6adf6d4dc,NA,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Eye,TCGA-UVM,NA,University of Liverpool,United Kingdom,NO,T2a,NX,Not available,Stage IIA,A40D-26,TRUE,0.005492048
13722.58cfa831e4b0c9d6adf6c42c,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,University of Pittsburgh,United States,NO,T3a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A210-26,TRUE,0.387265196
13722.58cfa832e4b0c9d6adf6ce19,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A21C-26,TRUE,0.999354635
13722.58cfa832e4b0c9d6adf6d3f0,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T3b,N0,Not available,Stage IIIA,A40D-26,TRUE,0.067698794
13722.58cfa832e4b0c9d6adf6d3d7,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB,A40D-26,TRUE,0.008237985
13722.58cfa832e4b0c9d6adf6d400,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB,A40D-26,TRUE,0.030797842
13722.58cfa832e4b0c9d6adf6d4f4,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Cleveland Clinic Foundation,United States,NO,T2b,NX,Not available,Stage IIB,A40D-26,TRUE,0.043443191
13722.58cfa832e4b0c9d6adf6d582,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA,A40D-26,TRUE,0.013729686
13722.58cfa832e4b0c9d6adf6d586,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,808,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA,A40D-26,TRUE,0.018270178
13722.58cfa832e4b0c9d6adf6d590,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Cleveland Clinic Foundation,United States,NO,T3a,NX,Not available,Stage IIB,A40D-26,TRUE,0.01607545
13722.58cfa832e4b0c9d6adf6d61a,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Esophageal Carcinoma,Esophagus,TCGA-ESCA,NA,ILSbio,Vietnam,NO,T3,N0,Not available,Stage IIA,A267-26,TRUE,0.048854969
13722.58cfa831e4b0c9d6adf6c4ac,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,ILSbio,Vietnam,NO,T2,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A210-26,TRUE,0.101150174
13722.58cfa831e4b0c9d6adf6c6b6,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,NA,"University Health Network, Toronto",Canada,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II,2317-26,TRUE,0.399549157
13722.58cfa831e4b0c9d6adf6c7da,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,NA,MD Anderson Cancer Center,United States,NO,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I,2317-26,TRUE,0.029803402
13722.58cfa831e4b0c9d6adf6c828,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,NA,MD Anderson Cancer Center,United States,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II,2317-26,TRUE,0.45152707
13722.58cfa831e4b0c9d6adf6c837,NA,Dead,FEMALE,Not available,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,572,MD Anderson Cancer Center,United States,NO,T2,NX,Head and Neck Squamous Cell Carcinoma,Stage II,2317-26,TRUE,0.213813559
13722.58cfa831e4b0c9d6adf6cae0,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,Memorial Sloan Kettering,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage I,A221-26,TRUE,0.144243894
13722.58cfa832e4b0c9d6adf6ce0c,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,BLN - University Of Chicago,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A210-26,TRUE,0.200816361
13722.58cfa832e4b0c9d6adf6ce9c,NA,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,122,BLN - University Of Chicago,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A210-26,TRUE,0.03214882
13722.58cfa832e4b0c9d6adf6cfe0,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,International Genomics Consortium,United States,NO,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A233-26,TRUE,0.045669129
13722.58cfa832e4b0c9d6adf6d134,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,MD Anderson,United States,NO,Not available,Not available,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A233-26,TRUE,0.051388145
13722.58cfa832e4b0c9d6adf6d254,NA,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Memorial Sloan Kettering,United States,NO,T1b1,N0,Endometrioid Adenocarcinoma of Endocervix,Not available,A232-26,TRUE,0.008237985
13722.58cfa832e4b0c9d6adf6d269,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,ABS - Lahey Clinic,United States,NO,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A23Q-26,TRUE,0.02610695
13722.58cfa832e4b0c9d6adf6d490,NA,Alive,MALE,Not available,Not available,Uveal Melanoma,Eye,TCGA-UVM,NA,University of Liverpool,United Kingdom,NO,T2a,N0,Not available,Stage IIA,A40D-26,TRUE,0.027057928
13722.58cfa830e4b0c9d6adf6bf87,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,University of Pittsburgh,United States,NO,T1a,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A221-26,TRUE,0.062138332
13722.58cfa830e4b0c9d6adf6c266,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,604,Medical College of Wisconsin,United States,NO,Not available,Not available,Cervical Squamous Cell Carcinoma,Not available,A20X-26,TRUE,0.010983864
13722.58cfa831e4b0c9d6adf6c47a,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,University of Pittsburgh,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A221-26,TRUE,0.077626649
13722.58cfa831e4b0c9d6adf6c6c8,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,UNC,United States,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A21C-26,TRUE,0.146942684
13722.58cfa831e4b0c9d6adf6c772,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,NA,"University Health Network, Toronto",Canada,NO,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II,2317-26,TRUE,0.116567185
13722.58cfa831e4b0c9d6adf6c8e6,NA,Dead,MALE,BLACK OR AFRICAN AMERICAN,Not available,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,862,MD Anderson Cancer Center,United States,NO,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III,2317-26,TRUE,0.045820107
13722.58cfa831e4b0c9d6adf6c8de,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,Head and Neck,TCGA-HNSC,107,MD Anderson Cancer Center,United States,NO,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,2317-26,TRUE,0.023361417
13722.58cfa831e4b0c9d6adf6cb12,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Asterand,Russia,NO,T1b,N0,Cervical Squamous Cell Carcinoma,Not available,A20X-26,TRUE,0.018421156
13722.58cfa831e4b0c9d6adf6cbbe,NA,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Gynecologic Oncology Group,United States,NO,Not available,Not available,Endocervical Type of Adenocarcinoma,Not available,A20X-26,TRUE,0.018821156
13722.58cfa831e4b0c9d6adf6cbb4,NA,Alive,FEMALE,WHITE,Not available,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,Gynecologic Oncology Group,United States,NO,T2b,N1,Cervical Squamous Cell Carcinoma,Not available,A20X-26,TRUE,0.022961417
13722.58cfa831e4b0c9d6adf6cbf1,NA,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,University Health Network,Canada,NO,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A221-26,TRUE,0.102830513
13722.58cfa831e4b0c9d6adf6cc80,NA,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,MD Anderson,United States,NO,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A221-26,TRUE,0.129246553
13722.58cfa832e4b0c9d6adf6cdfc,NA,Alive,MALE,WHITE,HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,BLN - University Of Chicago,United States,NO,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A233-26,TRUE,0.046965119
13722.58cfa832e4b0c9d6adf6ce63,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,BLN - Cleveland Clinic,United States,NO,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A221-26,TRUE,0.090298576
13722.58cfa832e4b0c9d6adf6ce8b,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,International Genomics Consortium,United States,NO,T2,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A221-26,TRUE,0.088992792
13722.58cfa832e4b0c9d6adf6ce99,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,International Genomics Consortium,United States,NO,T3,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A221-26,TRUE,0.187471892
13722.58cfa832e4b0c9d6adf6cee4,NA,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,University Health Network,Canada,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A221-26,TRUE,0.233996866
13722.58cfa832e4b0c9d6adf6cf9f,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,Christiana Healthcare,United States,NO,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A221-26,TRUE,0.128638094
13722.58cfa832e4b0c9d6adf6d024,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,International Genomics Consortium,United States,NO,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A23Q-26,TRUE,0.025155973
13722.58cfa832e4b0c9d6adf6d042,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Cervix,TCGA-CESC,NA,International Genomics Consortium,United States,NO,T2b,N0,Endocervical Type of Adenocarcinoma,Not available,A20X-26,TRUE,0.008237985
13722.58cfa832e4b0c9d6adf6d026,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,NA,ABS - IUPUI,United States,NO,T4a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A221-26,TRUE,0.165249797
13722.58cfa832e4b0c9d6adf6d132,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,International Genomics Consortium,United States,NO,T2,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA,A221-26,TRUE,0.062206366
13722.58cfa832e4b0c9d6adf6d191,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,Thyroid,TCGA-THCA,NA,Ohio State University,United States,NO,T3,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A221-26,TRUE,0.029803402
13722.58cfa832e4b0c9d6adf6d3e3,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA,A40D-26,TRUE,0.01607545
13722.58cfa832e4b0c9d6adf6d49c,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA,A40D-26,TRUE,0.010183864
13722.58cfa832e4b0c9d6adf6d412,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,730,Institut Curie,France,NO,T4a,N0,Not available,Stage IIIA,A40D-26,TRUE,0.008237985
13722.58cfa832e4b0c9d6adf6d4e5,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uveal Melanoma,Eye,TCGA-UVM,NA,Institut Curie,France,NO,T3a,N0,Not available,Stage IIB,A40D-26,TRUE,0.012129686
13722.58cfa832e4b0c9d6adf6d4cc,NA,Alive,FEMALE,Not available,Not available,Uveal Melanoma,Eye,TCGA-UVM,NA,University of Liverpool,United Kingdom,NO,T3a,NX,Not available,Stage IIB,A40D-26,TRUE,0.01607545
13722.58cfa831e4b0c9d6adf6ca5a,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,Bladder,TCGA-BLCA,250,Memorial Sloan Kettering,United States,NO,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A210-26,TRUE,0.018821156